Literature DB >> 29454515

Quantitative profiling reveals minor changes of T cell receptor repertoire in response to subunit inactivated influenza vaccine.

Anastasiia L Sycheva1, Mikhail V Pogorelyy1, Ekaterina A Komech2, Anastasia A Minervina1, Ivan V Zvyagin2, Dmitriy B Staroverov2, Dmitriy M Chudakov3, Yuri B Lebedev2, Ilgar Z Mamedov4.   

Abstract

Vaccination against influenza is widely used to protect against seasonal flu epidemic although its effectiveness is debated. Here we performed deep quantitative T cell receptor repertoire profiling in peripheral blood of a healthy volunteer in response to trivalent subunit influenza vaccine. We did not observe significant rebuilding of peripheral blood T cell receptors composition in response to vaccination. However, we found several clonotypes in memory T cell fraction that were undetectable before the vaccination and had a maximum concentration at day 45 after vaccine administration. These cells were found in lower concentration in the course of repertoire monitoring for two years period. Our observation suggests a potential for recruitment of only a limited number of new T cells after each seasonal influenza vaccination.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  High-throughput sequencing; Inactivated influenza vaccine; T cell receptor; TCR repertoires

Mesh:

Substances:

Year:  2018        PMID: 29454515     DOI: 10.1016/j.vaccine.2018.02.027

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases.

Authors:  Pierre Barennes; Valentin Quiniou; Mikhail Shugay; Evgeniy S Egorov; Alexey N Davydov; Dmitriy M Chudakov; Imran Uddin; Mazlina Ismail; Theres Oakes; Benny Chain; Anne Eugster; Karl Kashofer; Peter P Rainer; Samuel Darko; Amy Ransier; Daniel C Douek; David Klatzmann; Encarnita Mariotti-Ferrandiz
Journal:  Nat Biotechnol       Date:  2020-09-07       Impact factor: 54.908

Review 2.  Can We Improve Vaccine Efficacy by Targeting T and B Cell Repertoire Convergence?

Authors:  Katja Fink
Journal:  Front Immunol       Date:  2019-02-13       Impact factor: 7.561

3.  The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains.

Authors:  Mikalai Nienen; Ulrik Stervbo; Felix Mölder; Sviatlana Kaliszczyk; Leon Kuchenbecker; Ludmila Gayova; Brunhilde Schweiger; Karsten Jürchott; Jochen Hecht; Avidan U Neumann; Sven Rahmann; Timm Westhoff; Petra Reinke; Andreas Thiel; Nina Babel
Journal:  Front Immunol       Date:  2019-04-04       Impact factor: 7.561

Review 4.  Novel Approaches for The Development of Live Attenuated Influenza Vaccines.

Authors:  Pilar Blanco-Lobo; Aitor Nogales; Laura Rodríguez; Luis Martínez-Sobrido
Journal:  Viruses       Date:  2019-02-22       Impact factor: 5.048

Review 5.  Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly.

Authors:  Branca Pereira; Xiao-Ning Xu; Arne N Akbar
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

6.  Immune fingerprinting through repertoire similarity.

Authors:  Thomas Dupic; Meriem Bensouda Koraichi; Anastasia A Minervina; Mikhail V Pogorelyy; Thierry Mora; Aleksandra M Walczak
Journal:  PLoS Genet       Date:  2021-01-04       Impact factor: 5.917

7.  Surface NKG2C Identifies Differentiated αβT-Cell Clones Expanded in Peripheral Blood.

Authors:  Elena I Kovalenko; Ivan V Zvyagin; Maria A Streltsova; Artem I Mikelov; Sofya A Erokhina; William G Telford; Alexander M Sapozhnikov; Yury B Lebedev
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

8.  Inactivated tick-borne encephalitis vaccine elicits several overlapping waves of T cell response.

Authors:  Anastasiia L Sycheva; Ekaterina A Komech; Mikhail V Pogorelyy; Anastasia A Minervina; Shamil Z Urazbakhtin; Maria A Salnikova; Mikhail F Vorovitch; Eugene P Kopantzev; Ivan V Zvyagin; Alexander Y Komkov; Ilgar Z Mamedov; Yuri B Lebedev
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.